Literature DB >> 9874795

A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11.

C I Pearson1, A M Gautam, I C Rulifson, R S Liblau, H O McDevitt.   

Abstract

The N-terminal peptide Ac1-11 of myelin basic protein induces experimental autoimmune encephalomyelitis in H-2(u) and (H-2(u) x H-2(s)) mice but does not in H-2(s) mice. Ac1-11 binds weakly to the class II major histocompatibility complex (MHC) molecule I-Au but not at all to I-As. We have studied the interaction of Ac1-11 and I-Au as a model system for therapeutic intervention in the autoimmune response seen in experimental autoimmune encephalomyelitis. Two polymorphic residues that differ between I-Au and I-As, Y26beta and T28beta, and one conserved residue, E74beta, confer specific binding of Ac1-11 to I-Au. A fourth residue, R70beta in I-Au, affects both peptide binding and T cell recognition. These results are consistent with a model that places arginine at position five of Ac1-11 in pockets 4 and 7 of the MHC groove, which is formed in part by residues 26, 28, 70, and 74 of Abetau and places lysine at position four of Ac1-11, previously shown to be a major MHC contact, in hydrophobic pocket 6. The data indicate that the primary region of I-Au that confers specific binding of Ac1-11 lies in the center of the peptide binding groove rather than in the region that contacts the N terminus of the peptide, as has been shown for HLA DR and the homologous I-E molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9874795      PMCID: PMC15116          DOI: 10.1073/pnas.96.1.197

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Structures of an MHC class II molecule with covalently bound single peptides.

Authors:  D H Fremont; W A Hendrickson; P Marrack; J Kappler
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

2.  Crystal structure of I-Ak in complex with a dominant epitope of lysozyme.

Authors:  D H Fremont; D Monnaie; C A Nelson; W A Hendrickson; E R Unanue
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

3.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues.

Authors:  C A Scott; P A Peterson; L Teyton; I A Wilson
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

4.  Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis.

Authors:  L Fugger; J Liang; A Gautam; J B Rothbard; H O McDevitt
Journal:  Mol Med       Date:  1996-03       Impact factor: 6.354

5.  A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak.

Authors:  C A Nelson; N J Viner; S P Young; S J Petzold; E R Unanue
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

6.  X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II.

Authors:  A Dessen; C M Lawrence; S Cupo; D M Zaller; D C Wiley
Journal:  Immunity       Date:  1997-10       Impact factor: 31.745

7.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.

Authors:  P Ghosh; M Amaya; E Mellins; D C Wiley
Journal:  Nature       Date:  1995-11-30       Impact factor: 49.962

8.  Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft.

Authors:  C Lee; M N Liang; K M Tate; J D Rabinowitz; C Beeson; P P Jones; H M McConnell
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

9.  Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases.

Authors:  K W Wucherpfennig; J L Strominger
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

10.  A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice.

Authors:  L C Harrison; M C Honeyman; S Trembleau; S Gregori; F Gallazzi; P Augstein; V Brusic; J Hammer; L Adorini
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

View more
  4 in total

Review 1.  Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities.

Authors:  S M Anderton
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

2.  A previously unappreciated polymorphism in the beta chain of I-As expressed in autoimmunity-prone SJL mice: Combined impact on antibody, CD4 T cell recognition and MHC class II dimer structural stability.

Authors:  Katherine A Richards; Courtney Lavery; Grant L J Keller; Jim Miller; Brian M Baker; Andrea J Sant
Journal:  Mol Immunol       Date:  2022-01-05       Impact factor: 4.174

3.  CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity.

Authors:  Leigh A Stephens; David Gray; Stephen M Anderton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-15       Impact factor: 11.205

4.  Negative selection during the peripheral immune response to antigen.

Authors:  S M Anderton; C G Radu; P A Lowrey; E S Ward; D C Wraith
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.